A small clinical trial using gold nanoparticles that act as tumor-seeking missiles on a mission to remove prostate cancer has begun at The University of Texas Health Science Center at Houston (UTHealth). It is the first trial of its kind in the world.
The nanoparticles, or nanoshells, are made of small layers of silica glass formed into a sphere and wrapped in a thin layer of gold. The shells seek out and saturate cancerous cells, and their advanced vibrational properties are then harnessed to cause the tumorous tissue to pulse with extreme temperature when light is applied through a laser specifically designed to excite the particles. The oscillation kills the cancer cells while preserving the healthy tissue, avoiding the nerves and urinary sphincter. This procedure is the first in the world that is precise enough to potentially avoid negative ramifications like urinary incontinence or sexual impotency.
“This therapy could be life-changing for men diagnosed with prostate cancer and I’m honored to be among the first doctors the U.S. Food and Drug Administration approved to put it to the test,” said Steven Canfield, M.D., chair of the division of urology at McGovern Medical School at UTHealth, who recognized the possibility of the nanoparticles to treat prostate cancer and helped developed the trial to test the theory.
Prostate cancer begins when cells in a man’s prostate gland mutate and start to grow uncontrollably. Other than skin cancer, prostate is the most common cancer in American men, with an estimated 1 out of 9 men diagnosed. The American Cancer Society estimates 29,430 men died from the disease in 2018 alone.
Treatment options have traditionally included radical prostatectomy, which is the removal of the prostate gland and some of the tissue around it, radiation therapy and cryotherapy, among others. These methods carry the potential to have a negative impact on urinary function and sexual performance.
“The side effects of current prostate cancer treatments can be extremely traumatic. This new technology holds the potential to eliminate those life-altering effects, while still removing the cancer tissue and reducing hospital and recovery time,” Canfield said. “In fact, the first patient in the trial was actually riding a bike within a week of his treatment. The fusion of MRI and ultrasound imaging technology that we use to accurately identify and diagnose the cancer, combined with the extreme precision of the gold nanoshells in targeting the diseased cells, allows us to be incredibly accurate at obliterating them. I am excited as we continue tracking the progress of this groundbreaking improvement to prostate cancer care.”
Image Credit: Shutterstock / Uni. of Texas
News This Week
Inventors and scientists have been continuously working towards reducing the size of technological components. Room-sized computers to laptops that are slimmer than a pane of glass? It’s done. Huge bulky telephones to smartphones that [...]
You have witnessed a variety of nano-devices that were designed for tasks including delivering medicines within the body. All of them used to move in a variety of ways. However, the latest nano-device is [...]
Netra Rajesh is an undergraduate Engineering Science student specializing in Biomedical Systems Engineering. She is currently on her Professional Experience Year (PEY) at the Massachusetts Institute of Technology where her research lies at the [...]
Nearly half of the companies in Europe that call themselves AI start-ups don't in fact use artificial intelligence, a new report found. The research, published Tuesday by London-based venture capital firm MMC Ventures, found [...]
A new quantum sensor developed by researchers at the University of Waterloo's Institute for Quantum Computing (IQC) has proven it can outperform existing technologies and promises significant advancements in long-range 3D imaging and monitoring [...]
Summary: Researchers use nanotech to enhance vision in mice, enabling them to see infrared light as well as visible light. Source: Cell Press. Mice with vision enhanced by nanotechnology were able to see infrared [...]
Immune Aspects of Biopharmaceuticals and Nanomedicines Available from CRC Press 1st Edition Raj Bawa, Janos Szebeni, Thomas J Webster, Gerald F. Audette The enormous advances in the immunology of biotherapeutics and nanomedicines in the [...]
Artificial Intelligence - Ethics, Governance and Policy Challenges by Andrea Renda and CEPS Think Tank released. About the report: CEPS is launching a Task Force to try to bring back the AI debate to [...]
The Nanofacturing consortium has worked on a pan-European nanopharmaceutical project to develop new manufacturing methods and improve supply chain co-ordination to advance treatments for rare cancers, autoimmune diseases and viral infections. The Nanofacturing collaboration [...]
You know those little motes or floaters you that you sometimes see moving in your vision? Well, someday very soon, those could be robots. An international team of medical researchers has unveiled a new [...]
Scientists at the Helmholtz Zentrum München, a partner in the German Center for Lung Research, have presented a new imaging method in the scientific journal ACS Nano ("Three-Dimensional Quantitative Co-Mapping of Pulmonary Morphology and [...]
Note: This videoblog is in German. It was produced by the Institute of Art & Art Theory of the University of Cologne. Humanity faces epochal challenges in the age of digitization. In particular, [...]
Nanoscale drug-delivery capsules that release their therapeutic cargo when triggered by a temperature change could boost the efficacy and reduce the side effects of many drugs. Researchers at RIKEN have combined lipids and peptides [...]
In recent years, the number of targeted cancer drugs has continued to rise. However, conventional chemotherapeutic agents still play an important role in cancer treatment. These include platinum-based cytotoxic agents that attack and [...]